United States · Wires & real time · GlobeNewswire
Syndax’s Revuforj® (revumenib) Wins Prestigious 2026 Prix
Read the full article on GlobeNewswire Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (news.google.com)

